The U.S. Food and Drug Administration has approved Omeros' drug for a dangerous transplant complication in adults and ...

Shares of Agios Pharmaceuticals jumped nearly 16% on Wednesday after the U.S. Food and Drug Administration approved the ...

Packaged food makers and fast-food restaurants may be forced to overhaul more of their products next year as newly approved, ...

In the studies the company submitted to the FDA, people who took the daily Wegovy pill lost about the same amount of ...

Billions of prescriptions for generic drugs are filled in the U.S. annually. The FDA tests only a few dozen of them every ...

People covered by Obamacare and Medicaid may see health care costs rise, but for people on Medicare, Biden-era negotiated ...

But Eli Lilly's Zepbound is best in class. Zepbound caused greater average weight loss than Wegovy in a head-to-head study. And through the first nine months of 2025, Zepbound generated $9.3 billion ...

Below, STAT previews the three key questions that could define a potentially busy year in the worlds of substance use and ...

The US Food and Drug Administration on Monday approved a daily pill version of Novo Nordisk's weight-loss drug Wegovy, ...

The lawsuit challenges a Health and Human Services declaration last week that bars providers from Medicare and Medicaid.

Both Novo Nordisk’s and competitor Eli Lilly’s injectable GLP-1 drugs, Wegovy and Zepbound, have helped transform obesity ...

Historically, people with amyotrophic lateral sclerosis (ALS) experience a relentless decline in neurological function that ...